Atlas Trials

Evaluation of Early Use of Everolimus (EVE) on Cytomegalovirus (CMV) Infection in Renal Transplant Recipients

Clinical trial NCT01927588 · UNKNOWN

Trial details

NCT number
NCT01927588
Sponsor
Fundação Pró Rim
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Cytomegalovirus Infections
Start date
2013-08-01
Primary completion
2015-11-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.